awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26745673-1FFAAF1B-5D53-451C-B0DC-B2C4EC4549D9
Q26745673-1FFAAF1B-5D53-451C-B0DC-B2C4EC4549D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745673-1FFAAF1B-5D53-451C-B0DC-B2C4EC4549D9
Trial watch - inhibiting PARP enzymes for anticancer therapy
P2860
Q26745673-1FFAAF1B-5D53-451C-B0DC-B2C4EC4549D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745673-1FFAAF1B-5D53-451C-B0DC-B2C4EC4549D9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c2e1a597d4e0fc9b5e6121a3b1b0509d9237d843
P2860
The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma.